comparemela.com

Latest Breaking News On - Oligonucleotide discovery - Page 1 : comparemela.com

Silence Therapeutics (OTCMKTS:SLNCF) Stock Price Up 1 3%

Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) rose 1.3% during mid-day trading on Thursday . The company traded as high as $7.60 and last traded at $7.60. Approximately 698 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 1,171 shares. The stock had previously closed at $7.50. […]

Silence Therapeutics (OTCMKTS:SLNCF) Trading 1 3% Higher

Shares of Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) shot up 1.3% during mid-day trading on Thursday . The stock traded as high as $7.60 and last traded at $7.60. 698 shares were traded during trading, a decline of 40% from the average session volume of 1,171 shares. The stock had previously closed at […]

Silence Therapeutics (NASDAQ:SLN) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a research note released on Friday, Benzinga reports. HC Wainwright currently has a $75.00 price objective on the stock. Several other research firms have also commented on SLN. BMO Capital Markets initiated coverage on Silence Therapeutics in a research […]

Silence Therapeutics (LON:SLN) Share Price Passes Above Two Hundred Day Moving Average of $535 00

Silence Therapeutics plc (LON:SLN – Get Free Report)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 535 ($6.80) and traded as high as GBX 546 ($6.94). Silence Therapeutics shares last traded at GBX 535 ($6.80), with a […]

Silence Therapeutics (NASDAQ:SLN) Shares Down 7 4%

Silence Therapeutics (NASDAQ:SLN) Shares Down 7 4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.